Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Bitcoin jumps to all-time high above US$6,300 after CME says will launch a regulated trading venue

The Nasdaq-listed firm said the new futures contracts will be settled in cash, based on the CME ‘CF Bitcoin Reference Rate’ - a once-a-day reference rate of the US dollar price of bitcoin
Bitcoin
According to trade website Coindesk’s price index, the price of bitcoin jumped to as high as US$6,342.99

The value of Bitcoin jumped to an all-time high above $6,300 (£4,754) on Tuesday after the world’s largest futures market operator CME Group Inc (NASDAQ:CME) said it would launch a regulated trading venue for cryptocurrencies in the fourth quarter of 2017.

The Nasdaq-listed company said the new futures contracts will be settled in cash, based on the CME ‘CF Bitcoin Reference Rate’ - a once-a-day reference rate of the US dollar price of bitcoin.

READ: Bitcoin and Ethereum slump as China gets tough on cryptocurrencies

According to trade website Coindesk’s price index, which aggregates the prices quoted across several exchanges, the price of a bitcoin jumped to as high as US$6,342.99, up 3.6% on the day.

Bitcoin has surged in value by around 555% so far this year despite criticism of the crypocurrency by the likes of JPMorgan Chase & Co (NYSE:JPM) boss, Jamie Dimon, and a clampdown on trading of them in China.

In August, the Chicago Board Options Exchange, the largest US options exchange, said its CBOE Futures Exchange planned to offer cash-settled bitcoin futures in the fourth quarter of this year or sometime in early 2018.

View full PROAC profile View Profile

Proactiveinvestors Timeline

Related Articles

White board with marketing ideas
March 13 2017
There was a bit of a wobble in the run-up to the Brexit vote and shortly after it, but the group's 'buy, build & grow' strategy is taking shape
marketing
Wed
Next Fifteen Communications expects another strong performance in the second half
1505911280_social-media.jpg
September 20 2017
The Cello Health unit led the way as it grew organically and via the acquisition

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use